Philips Launches IntraSight Plus to Simplify Coronary Interventions and Advance Precision Care

Why It Matters

By consolidating diagnostic and therapeutic tools, IntraSight Plus can accelerate PCI workflows, improve precision, and lower operating costs for hospitals, potentially reshaping standards in cath‑lab care.

Key Takeaways

• IntraSight Plus cleared FDA, CE marked.
• Claims up to 47% procedure time reduction.
• Merges IVUS, iFR/FFR, imaging on single screen.
• Enables bedside control, reduces data entry.
• Philips 2025 sales ≈ $19.8 billion.

Pulse Analysis

The interventional cardiology landscape is rapidly evolving as clinicians demand more data‑driven decision support without sacrificing procedural speed. Integrated platforms that combine imaging, physiology, and planning tools address a long‑standing fragmentation in cath‑lab workflows, where separate consoles for IVUS, FFR and angiography increase setup time and cognitive load. Market analysts project that the global PCI device market will exceed $30 billion by 2028, driven by aging populations and the shift toward minimally invasive therapies, creating fertile ground for solutions like IntraSight Plus.

IntraSight Plus differentiates itself by embedding Class IA IVUS and real‑time iFR/FFR measurements into a unified interface that co‑registers anatomical and functional data. Early simulation studies suggest up to a 47% cut in system operation time, translating into higher case throughput and reduced radiation exposure for staff. The platform’s bedside‑centric design also minimizes sterile‑field disruptions, allowing physicians to maintain focus on lesion assessment and stent deployment. Such efficiency gains are especially valuable in high‑volume centers where procedural bottlenecks directly impact revenue and patient wait times.

For Philips, the launch reinforces its strategic pivot toward integrated health‑technology ecosystems, complementing its Azurion suite and enterprise informatics portfolio. While competitors like Abbott and Boston Scientific are also expanding imaging‑guided PCI offerings, Philips’ ability to bundle hardware, software, and data management under a single architecture could accelerate adoption among institutions already invested in its ecosystem. If the promised time savings and precision translate into measurable outcome improvements, hospitals may prioritize IntraSight Plus, potentially reshaping market share dynamics in the next few years.